The same compound proved to inhibit DYRK1A-catalyzed τ phosphorylation in stably transfected HEK293 cells and due to its favorable physicochemical properties might be potentially applicable to in vivo AD models [164]. The gene discussed is DYRK1A; the disease is Alzheimer disease.